System grading doctors is inefficient, needs revisions

A system created to grade doctors and empower patients to make better decisions falls short of its goal of providing information useful to consumers, according to a study by University of Michigan researchers.

Oncology & Cancer

Recurrence score may cut costs for high-risk breast cancer care

(HealthDay)—Genomic recurrence score (RS) testing using a 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients with breast cancer who would otherwise receive standard ...

page 1 from 23